Retatrutide has emerged as a new medication in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By stimulating these receptors, Retatrutide suppresses appetite, {promotesinsulin secretion, and ultimately leads to significant weight loss. While